Article
Health Services Provider’s Settlement With DOJ Includes Detailed Factual Admissions And Agreement To Cooperate Against Co-Defendant Pharmaceutical Company
On January 8, 2014, pharmaceutical provider BioScrip, Inc. (BioScrip) reached a settlement with the Department of Justice (DOJ) to resolve claims under the False Claims Act (FCA) and the Anti-Kickback Statute (AKS), stemming from an alleged multi-million-dollar health care fraud involving the drug Exjade.

Ropes & Gray LLP











